Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BNIP3 pseudogene 47 (BNIP3P47) is annotated as a pseudogene in the human genome and is classified as non-protein-coding[6]. Pseudogenes are gene sequences that resemble known functional genes but have lost their protein-coding ability due to mutations or truncations. There is no experimental data supporting a protein product or functional activity for BNIP3P47. It shares sequence similarity with the functional BNIP3 gene, which encodes a mitochondrial protein involved in cell death and autophagy, but BNIP3P47 has no identified role in human physiology or disease and is not recognized as a therapeutic target or biomarker[6]. No data exist to suggest that BNIP3P47 interacts with any drugs, serves as a biomarker, or presents therapeutic safety concerns. It is not referred to in disease contexts or mechanistic pathways in the literature. Its classification as a pseudogene suggests either a mistaken target entry, lack of biological relevance, or misspecification. For structured data purposes, entries such as biological function, disease role, and mechanism of action should be left null.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BNIP3 pseudogene 47 (BNIP3P47).